(1)
Rifampicin in Cutaneous Leishmaniasis – a Therapeutic Trial in Saudi Arabia. J Pak Assoc Dermatol 2017, 16 (1), 4-9. https://doi.org/10.66344/jpad.16.1.2006.838.